Bone Biologics Corporation (BBLG) Analyst Estimates Quarterly

Bone Biologics Corporation

BBLG (NASDAQ)

(%)

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2026 12-31	2026 03-31	2025 12-31	2025 09-30
Number of Analysts	1234	0	0	0
Estimated Revenue
Low	1234	0	0	0
Average	1234	0	0	0
High	1234	0	0	0
Estimated EBITDA
Low	1234	0	0	0
Average	1234	0	0	0
High	1234	0	0	0
Estimated EBIT
Low	1234	0	0	0
Average	1234	0	0	0
High	1234	0	0	0
Estimated Net Income
Low	1234	-0.634	-0.399	-0.664
Average	1234	-0.634	-0.399	-0.664
High	1234	-0.634	-0.399	-0.664
Estimated SGA Expenses
Low	1234	0	0	0
Average	1234	0	0	0
High	1234	0	0	0
Estimated EPS
Low	1234	-0.54	-0.34	-0.37
Average	1234	-0.54	-0.34	-0.37
High	1234	-0.54	-0.34	-0.37

Market is Open